Effect of Covid is seen on the stock market!!!
Effect of Covid is seen on the stock market!!!
The effect of this wave of Covid is being seen on the stock market. On the other hand, there was a rise in the shares of health sectors on Wednesday. As reports of a sudden surge in COVID-19 cases in china, Japan, the United States, the Republic of Korea and Brazil, the Union health Ministry held a meeting on the COVID-19 situation on 21 December.Among individual stocks, Vijaya Diagnostic Center gained 8 per cent to Rs 461.95 on the BSE in intra-day trade today. Dr Lal PathLabs gained 6 per cent to Rs 2,434.70, followed by Metropolis Healthcare (up 5 per cent to Rs 1,342) and Thyrocare Technologies (up 3 per cent to Rs 630.30).Apart from these four stocks, IOL Chemicals & Pharmaceuticals, supriya Lifescience, Panacea Biotec, Vimta Labs, Glenmark from S&P BSE Healthcare Index Pharmaceuticals (Glenmark Pharmaceuticals) and Granules india (Granules India) saw a gain of 4 percent to 12 percent on BSE. In comparison, the S&P BSE Sensex closed at 61,564, down 0.22 per cent.Serum Institute CEO Poonawalla chirped on Wednesday, “While the news of rising COVID cases from china is worrying, we need not panic considering our better vaccination coverage and track record. We must continue to rely on and follow the guidelines set by the government of india and the Ministry of health and Family Welfare, government of India.”
The effect of this wave of Covid is being seen on the stock market. On the other hand, there was a rise in the shares of health sectors on Wednesday. As reports of a sudden surge in COVID-19 cases in china, Japan, the United States, the Republic of Korea and Brazil, the Union health Ministry held a meeting on the COVID-19 situation on 21 December.Among individual stocks, Vijaya Diagnostic Center gained 8 per cent to Rs 461.95 on the BSE in intra-day trade today. Dr Lal PathLabs gained 6 per cent to Rs 2,434.70, followed by Metropolis Healthcare (up 5 per cent to Rs 1,342) and Thyrocare Technologies (up 3 per cent to Rs 630.30).Apart from these four stocks, IOL Chemicals & Pharmaceuticals, supriya Lifescience, Panacea Biotec, Vimta Labs, Glenmark from S&P BSE Healthcare Index Pharmaceuticals (Glenmark Pharmaceuticals) and Granules india (Granules India) saw a gain of 4 percent to 12 percent on BSE. In comparison, the S&P BSE Sensex closed at 61,564, down 0.22 per cent.Serum Institute CEO Poonawalla chirped on Wednesday, “While the news of rising COVID cases from china is worrying, we need not panic considering our better vaccination coverage and track record. We must continue to rely on and follow the guidelines set by the government of india and the Ministry of health and Family Welfare, government of India.”